The Hindu·3 min read·medium
Merck inks pact with four generic drugmakers in India for HIV drug
T
The Hindu Bureau
✦AI Summary
Merck has signed voluntary licensing agreements with four Indian generic drugmakers to manufacture and supply the investigational HIV pill Alimatravir. The deal covers 129 low- and middle-income countries and aims to improve global access to HIV prevention treatments.
Pharma major Merck (known as MSD outside of the U.S. and Canada) has signed non-exclusive voluntary licensing agreements with generic drugmakers Aurobindo Pharma, Cipla, Emcure and Viatris in India to enable supply of its investigational, once-monthly oral pill HIV pill Alimatravir.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in